EXAS vs INTS
EXACT Sciences Corporation (EXAS) versus Intensity Therapeutics, Inc. Common stock (INTS) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
INTS does not have a complete income-statement cache yet.
EXAS currently screens at market cap $20.03B. INTS currently screens at market cap $7.7M.
Not investment advice. Open the EXAS and INTS stock pages for the full models.
Not investment advice.